← Open Payments lookup

STUART PORTER: Open Payments

NPI 1689612996 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$802 in 43 payments from 10 companies in 2025. Trend: 2023 $439 · 2024 $995 · 2025 $802

Food & beverage: $802
CompanyPaymentsAmount
ABBVIE INC.22$381
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$135
Supernus Pharmaceuticals, Inc.3$55
Collegium Pharmaceutical, Inc.3$52
Takeda Pharmaceuticals U.S.A., Inc.2$48
Aimmune Therapeutics, Inc.2$42
Axsome Therapeutics, Inc.1$30
Neurocrine BioSciences, Inc.1$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$20
PFIZER INC.1$16

Products named: QULIPTA, CAPLYTA, UBRELVY, Qelbree, VRAYLAR, Jornay PM, TRINTELLIX, ZENPEP.

Industry payments across UT — which companies pay providers there.